Olmetime-CT 40mg 10 Tablets

Babies: It does not apply to babies. Lactating mothers: It is safe to use if given in prescribed amounts.
Pregnancy: It is unsafe to use in pregnancy. Seek doctor advice before using this medication.
Driving: Chlorthalidone and olmesartan medoxmil tablet may decrease alertness, affect your vision and make you feel dizzy & sleepy. Do not drive if these symptoms occur.
Alcohol: Avoid consuming alcohol while taking this medicine as it may cause some side effects. Liver: Chlorthalidone and olmesartan medoxmil tablets should use in caution with patients suffering from liver patients.
Seek doctor advice before using this medication. Kidney: Chlorthalidone and olmesartan medoxmil tablets should use in caution with patients suffering from kidney patients.
Seek doctor advice before using this medication. .

Nausea Weakness Glucose intolerance Electrolyte imbalance Increased blood uric acid.

It works by blocking the angiotensin at its receptor, thereby relaxing blood vessels, then allows the blood to flow more smoothly & efficiently. It also removes extra water and electrolytes from the body, decreases the volume load & controls the blood pressure..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Take this tablet with food as directed by your physician • Drink plenty of water as this tablet may cause dehydration • Seek immediate medical advice if you experience any unusual side effects from this tablet • Before taking this medicine, inform your doctor if you are pregnant or intend to pregnant.

• Chlorthalidone + Alfuzosin: Concurrent use may increase the hypotensive effect • Chlorthalidone + Amiloride: Concurrent use may increase the risk of adverse effects • Olmesartan medoxmil + Acemetacin: Concurrent use may provoke increased risk of renal failure, hypertension and hyperkalemia • Olmesartan medoxmil + Alfentanil: Concurrent use may decrease the antihypertensive activity of olmesartan.